Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome

Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome

US Patent 11324834 · Granted May 10, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-specific delayed-type hypersensitivity response to treat herpes simplex viru2024
Topical immunosensitizers to treat viral and fungal infections2024
Fusion proteins containing insulin-like growth factor-1 and epidermal growth fac2021
Non-specific delayed-type hypersensitivity response to treat herpes simplex viru2021
Non-specific delayed-type hypersensitivity response to treat herpes simplex viru2020
Fusion proteins containing insulin-like growth factor-1 and epidermal growth fac2019
Non-specific delayed-type hypersensitivity response to treat herpes simplex viru2019
Fusion proteins containing insulin-like growth factor-1 and epidermal growth fac2017
Fusion proteins containing insulin-like growth factor-1 and epidermal growth fac2017
Non-specific delayed-type hypersensitivity response to treat herpes simplex viru2015
Compounds and methods for treating cancer2015
Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of canc2014